In the article “Prasugrel as Antiplatelet Therapy in Patients With Acute Coronary Syndromes or Undergoing Percutaneous Coronary Intervention” (October 2010:45–54), Table 1 (on page 46) incorrectly lists the antiplatelet agent Angiomax as a glycoprotein IIb/IIIa inhibitor; Angiomax is a direct thrombin inhibitor.
Corrections| February 01 2011
Crit Care Nurse (2011) 31 (1): 15.
- Views Icon Views
- Share Icon Share
Corrections. Crit Care Nurse 1 February 2011; 31 (1): 15. doi:
Download citation file: